66th American Society of Hematology Annual Meeting & Exposition Posts
How is transfusion dependence evolving in anemia treatment in MDS?
In this segment of the MDS roundtable on anemia in lower-risk MDS, the panel, led by Guillermo Garcia-Manero discuss transfusion dependence.
What do the recent long-term COMMANDS data show?
Dr. Guillermo Garcia-Manero and the panel discuss long-term data from the COMMANDS trial in lower-risk MDS.
What are second line treatments in lower-risk MDS with anemia?
A roundtable discussion on anemia management in myelodysplastic syndromes. Featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy DeZern, MD, MHS, Johns Hopkins Medicine; […]
How do you treat patients with MDS and anemia?
A roundtable discussion on anemia management in myelodysplastic syndromes, featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy DeZern, MD, MHS, Johns Hopkins Medicine; […]
What novel therapies were discussed at ASH 2024?
A roundtable discussion on anemia management in myelodysplastic syndromes featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy DeZern, MD, MHS, Johns Hopkins Medicine; […]
Multiple myeloma updates with Dr. Lonial
In a video interview during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, California, Sagar Lonial, MD, FACP, discusses multiple myeloma updates from the […]
